AHI1 Antikörper (AA 1-12)
Kurzübersicht für AHI1 Antikörper (AA 1-12) (ABIN1885582)
Target
Alle AHI1 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 1-12
-
Aufreinigung
- Purified by antigen-affinity chromatography.
-
Immunogen
- Synthetic peptide contain a sequence corresponding to a region within amino acids 1 and 12 of Jouberin
-
-
-
-
Applikationshinweise
-
Suggested dilutions:
Western blotting: 1.500-1.3000 -
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Buffer
- 0.1 M Tris-buffered saline with 10 % Glycerol (pH 7.0).0.01 % Thimerosal was added as a preservative.
-
Konservierungsmittel
- Thimerosal (Merthiolate)
-
Vorsichtsmaßnahmen
- Biohazard Informations: This product contains thimerosal which is hazardous.
-
Lagerung
- 4 °C/-20 °C
-
Informationen zur Lagerung
- Store at -20 °C for long term preservation (recommended). Store at 4 °C for short term use.
-
-
- AHI1 (Abelson Helper Integration Site 1 (AHI1))
-
Andere Bezeichnung
- Jouberin
-
Hintergrund
-
This gene is apparently required for both cerebellar and cortical development in humans.This gene mutations cause specific forms of Joubert syndrome-related disorders.Joubert syndrome (JS) is a recessively inherited developmental brain disorder with several identified causative chromosomal loci.Alternatively spliced transcript variants encoding different isoforms have been identified.[provided by RefSeq]
Synonyms: ORF1, AHI-1, JBTS3, FLJ14023, FLJ20069, dJ71N10.1, DKFZp686J1653 -
Molekulargewicht
- 137 kDa
-
Gen-ID
- 54806
-
NCBI Accession
- NP_060121, NM_017651
Target
-